{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:52:04Z","timestamp":1792003924713,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["899871"],"award-info":[{"award-number":["899871"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["101136244"],"award-info":[{"award-number":["101136244"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["101080189"],"award-info":[{"award-number":["101080189"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejim.2026.106751","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:15:08Z","timestamp":1770466508000},"page":"106751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Direct oral anticoagulants versus Vitamin K antagonist in kidney transplant recipients with atrial fibrillation: A study from a global federated research network"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6454-2736","authenticated-orcid":false,"given":"Michele","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Askarinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Galeazzo","family":"Rigutini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-1428","authenticated-orcid":false,"given":"Muath","family":"Alobaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirudh","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Oni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3594-2503","authenticated-orcid":false,"given":"Claudio","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.106751_bib0001","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2026.106751_bib0002","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106751_bib0003","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/ajt.12197","article-title":"Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation","volume":"13","author":"Lenihan","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejim.2026.106751_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"B. Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2026.106751_bib0005","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(20)32439-9","article-title":"Direct oral anticoagulants: evidence and unresolved issues","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2026.106751_bib0006","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective","volume":"124","author":"Potpara","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2026.106751_bib0007","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.3390\/cells11203214","article-title":"Anticoagulants: a short history, their mechanism of action, pharmacology, and indications","volume":"11","author":"Heestermans","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejim.2026.106751_bib0008","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2026.106751_bib0009","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2026.106751_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/10760296251347938","article-title":"Oral anticoagulants in women: what's the difference? A narrative review","volume":"31","author":"Faioni","year":"2025","journal-title":"Clin Appl Thromb\/Hemost"},{"key":"10.1016\/j.ejim.2026.106751_bib0011","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ajt.2024.01.012","article-title":"OPTN\/SRTR 2022 annual data report: kidney","volume":"24","author":"Lentine","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejim.2026.106751_bib0012","doi-asserted-by":"crossref","DOI":"10.5500\/wjt.v14.i4.96017","article-title":"Cardiac evaluation of renal transplant candidates with heart failure","volume":"14","author":"Belal","year":"2024","journal-title":"World J Transpl"},{"key":"10.1016\/j.ejim.2026.106751_bib0013","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2026.106751_bib0014","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jacc.2016.06.057","article-title":"Atrial fibrillation and thromboembolism in patients with chronic kidney disease","volume":"68","author":"Lau","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2026.106751_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102974","article-title":"Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation status","volume":"78","author":"Bucci","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejim.2026.106751_bib0016","article-title":"Adherence to the ABC (atrial fibrillation better care) pathway and risk of adverse outcomes in patients with chronic kidney disease: a report from the prospective APHRS-AF registry","volume":"58","author":"Bucci","year":"2025","journal-title":"Lancet Reg Health 13Western Pac"},{"key":"10.1016\/j.ejim.2026.106751_bib0017","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5500\/wjt.v9.i6.134","article-title":"Efficacy and safety of non-vitamin K antagonist oral anticoagulants post-kidney transplantation","volume":"9","author":"Bukhari","year":"2019","journal-title":"World J Transpl"},{"key":"10.1016\/j.ejim.2026.106751_bib0018","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14474","article-title":"Can direct oral anticoagulants be used in kidney transplant recipients?","volume":"35","author":"Parker","year":"2021","journal-title":"Clin Transpl"},{"key":"10.1016\/j.ejim.2026.106751_bib0019","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40256-024-00692-y","article-title":"Use of direct anticoagulants in kidney transplant recipients: review of the current evidence and emerging perspectives","volume":"25","author":"Afsar","year":"2025","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ejim.2026.106751_bib0020","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2026.106751_bib0021","article-title":"Safety and efficacy of direct oral anticoagulants in kidney transplant recipients: a systematic review and meta-analysis","volume":"39","author":"Mora","year":"2025","journal-title":"Transpl Rev"},{"key":"10.1016\/j.ejim.2026.106751_bib0022","first-page":"1612","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"EP Eur"},{"key":"10.1016\/j.ejim.2026.106751_bib0023","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1097\/TP.0000000000003168","article-title":"Efficacy and safety of direct oral anticoagulants in kidney transplantation: a single-center pilot experience","volume":"104","author":"Leon","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2026.106751_bib0024","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/tri.13599","article-title":"Safety and efficacy of direct-acting oral anticoagulants versus warfarin in kidney transplant recipients: a retrospective single-center cohort study","volume":"33","author":"Bixby","year":"2020","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejim.2026.106751_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/FTD.0000000000000356","article-title":"Effect of the direct oral anticoagulants rivaroxaban and apixaban on the disposition of calcineurin inhibitors in transplant recipients","volume":"39","author":"Vanhove","year":"2017","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ejim.2026.106751_bib0026","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl j med"},{"key":"10.1016\/j.ejim.2026.106751_bib0027","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106751_bib0028","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106751_bib0029","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106751_bib0030","article-title":"Safety and efficacy of factor Xa inhibitors in atrial fibrillation patients on dialysis: evidence from four randomized controlled trials","author":"Kaisaier","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2026.106751_bib0031","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejim.2023.08.003","article-title":"Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: direct oral anticoagulants versus vitamin-k antagonists","volume":"119","author":"Santoro","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2026.106751_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285412","article-title":"Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients","volume":"18","author":"Firth","year":"2023","journal-title":"Plos one"},{"key":"10.1016\/j.ejim.2026.106751_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034641","article-title":"Risk of major bleeding, stroke\/systemic embolism, and death associated with different Oral anticoagulants in patients with atrial fibrillation and severe chronic kidney disease","volume":"13","author":"Xu","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2026.106751_bib0034","series-title":"The Use of Non\u2013Vitamin K Antagonist Oral Anticoagulants in Post-Kidney Transplantation, Single-Center ExperienceTransplantation Proceedings","first-page":"2918","author":"Zaitoun","year":"2021"},{"key":"10.1016\/j.ejim.2026.106751_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12873","article-title":"Direct oral anticoagulant considerations in solid organ transplantation: a review","volume":"31","author":"Salerno","year":"2017","journal-title":"Clin Transpl"},{"key":"10.1016\/j.ejim.2026.106751_bib0036","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra0902927","article-title":"Rejection of the kidney allograft","volume":"363","author":"Nankivell","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2026.106751_bib0037","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/heartjnl-2019-315307","article-title":"Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study","volume":"106","author":"Banerjee","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2026.106751_bib0038","series-title":"Guideline-adherent antithrombotic treatment improves outcomes in patients with atrial fibrillation: insights from the community-based Darlington atrial fibrillation registryMayo Clinic Proceedings","first-page":"1203","author":"Mazurek","year":"2017"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620526000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:11:10Z","timestamp":1780139470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620526000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"alternative-id":["S0953620526000567"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106751","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct oral anticoagulants versus Vitamin K antagonist in kidney transplant recipients with atrial fibrillation: A study from a global federated research network","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106751"}}